Shukra Pharmaceuticals Share Price
19 Oct, 2026 12:09 PM (IST)
Shukra Pharmaceuticals Performance
- Today's Low
- ₹68
- Today's High
- ₹70
- 52 Week Low
- ₹26
- 52 Week High
- ₹76
- Open Price₹68
- Previous Close₹69
- Volume1,087,041
- 50 DMA₹54.70
- 100 DMA₹47.40
- 200 DMA₹41.60
Shukra Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 22.75%
- Over 3 Month + 107.33%
- Over 6 Month + 90.49%
- Over 1 Year + 84.5%
Smart Investing Starts Here Start SIP with Shukra Pharmaceuticals for Steady Growth!
Shukra Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 89.4
- PEG Ratio
- 0.4
- Market Cap Cr
- 3,040
- P/B Ratio
- 29.4
- Average True Range
- 3.5
- EPS
- 0.8
- Dividend Yield
- 0
- MACD Signal
- 4.6
- RSI
- 70.7
- MFI
- 78.06
Latest Stock News Updates
Change of Name by MCA
- BSE India
- 6 days 17 hours ago
Reg 74(5)
- BSE India
- 1 week 1 day ago
Allotment of Shares pursuant to conversion of Warrants
- BSE India
- 1 week 5 days ago
Shukra Pharmaceuticals Financials
Shukra Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹63.30
- 50 Day
- ₹54.70
- 100 Day
- ₹47.40
- 200 Day
- ₹41.60
Resistance and Support
- R3 76.50
- R2 74.20
- R1 71.50
- S1 66.60
- S2 64.20
- S3 61.60
Shukra Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-22 | A.G.M. | |
| 2026-08-12 | Quarterly Results | |
| 2026-06-10 | Others | Inter-alia, to consider 1. Ratification of Approval for member's resolution passed in the EGM. 2. To approve draft of notice of postal ballot. 3. Other business matters. |
| 2026-05-07 | Audited Results & Final Dividend | |
| 2026-03-16 | Others | Inter-alia, to consider 1. To review the performance of Non-Independent Directors and the Board as a whole. 2. To Review the performance of the Chairman of the Company. 3. Other business matters. |
About Shukra Pharmaceuticals
Shukra Pharmaceuticals is engaged in the manufacturing, marketing, and export of pharmaceutical formulations. The Company caters to both domestic and international markets, with a growing presence in countries such as Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen. View More- NSE Symbol
- SHUKRAPHAR
- BSE Symbol
- 524632
- ISIN
- INE551C01044
Similar Stocks to Shukra Pharmaceuticals
Popular Stocks
Shukra Pharmaceuticals FAQs
Shukra Pharmaceuticals share price is ₹68 As on 19 October, 2026 | 11:57
The Market Cap of Shukra Pharmaceuticals is ₹3039.7 Cr As on 19 October, 2026 | 11:57
The P/E ratio of Shukra Pharmaceuticals is 89.4 As on 19 October, 2026 | 11:57
The PB ratio of Shukra Pharmaceuticals is 29.4 As on 19 October, 2026 | 11:57
The 52 week High & Low of Shukra Pharmaceuticals is ₹75.5/₹26.3 respectively As on 19 October, 2026 | 11:57
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.